GlassScriptPhysician profile
Ryan M Levy
NPI 1770785404
$10,199.60
in general payments reported to CMS, 2019-2025
16 companies · $4,944 in 2025
The $4,944 reported for 2025 was more than what 90% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,000 · 2020: $350 · 2021: $117 · 2022: $1,510 · 2023: $478 · 2024: $1,802 · 2025: $4,944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,258 · Consulting Fee: $1,343 · Travel and Lodging: $951 · Honoraria: $500 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,257.88 |
| Consulting Fee | $1,342.50 |
| Travel and Lodging | $951.25 |
| Honoraria | $500.00 |
| Education | $171.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,697.67 | 2019-2025 | Monarch |
| Astrazeneca Pharmaceuticals LP | $1,497.17 | 2025 | Imfinzi |
| Ethicon INC. | $1,484.91 | 2020-2025 | Monarch Platform |
| On Target Laboratories, INC | $1,218.78 | 2024-2025 | Cytalux |
| Atricure, INC. | $982.37 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $839.46 | 2022-2025 | Signet, Endo Gia Ultra, Micra |
| Intuitive Surgical, INC. | $703.45 | 2019-2025 | |
| Elucent Medical | $500.00 | 2024 | |
| Galvanize Therapeutics, INC | $401.83 | 2022-2024 | Aliya System |
| Davol INC. | $344.55 | 2019-2024 | Progel Applicator Spray Tips |
| Abbott Laboratories | $190.82 | 2025 | Navitor |
| Ethicon US, LLC | $167.28 | 2024-2025 | Evarrest, Harmonic, Prolene |
| Noah Medical Corporation | $75.63 | 2025 | Galaxy |
| Ethicon Endo-Surgery INC. | $64.34 | 2024 | Linx Reflux Management System, Echelon; Endopath |
| Regeneron Healthcare Solutions, INC. | $31.34 | 2024 | Dupixent |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.